Article

ISG20L2 as a Novel Prognostic Biomarker Facilitates the Progression of Pancreatic Cancer Via Glycolysis

2021-10-14

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold> Longstanding type 2 diabetes mellitus (T2DM) is an increased risk of pancreatic cancer (PC) in western populations, and PC is also a cause of T2DM. However, the association of glucose metabolism between T2DM and PC remains unclear. <bold>Methods:</bold> Differentially expressed genes (DEGs) were identified by bioinformatic analysis from Gene Expression Omnibus...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ab9bb7ff-5255-5432-9db3-ef21a80d39ea
DOI: 10.21203/rs.3.rs-900506/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ISG20L2 as a Novel Prognostic Biomarker Facilitates the Progression of Pancreatic Cancer Via GlycolysisDOI 10.21203/rs.3.rs-900506/v2Read

The glycolytic PKM gene is associated with immune infiltrates and therapeutic response of pancreatic cancerSemantic proximity Read

Identification of a glycolysis-related gene signature for predicting pancreatic cancer survivalSemantic proximity Read

Integrative analyzes of biomarkers and pathways for exploration the mechanisms and targets associated with pyroptosis in type 2 diabetesSemantic proximity Read

Glycolysis-Related Gene Expression Profiling Screen for Prognostic Risk Signature of Pancreatic Ductal AdenocarcinomaSemantic proximity Read

A novel 20-gene prognostic score in pancreatic adenocarcinomaSemantic proximity Read

The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic CancerSemantic proximity Read

PKM2 modulates chemotherapy sensitivity by regulating autophagy and predicts the prognosis and immunity in pancancerSemantic proximity Read

Metabolic Syndrome Related Gene Signature Predicts the Prognosis of Patients With Pancreatic Ductal Carcinoma. A Novel Link Between Metabolic Dysregulation and Pancreatic Ductal Carcinoma.Semantic proximity Read

LncRNA YIYA enhances pancreatic cancer proliferation under high-glucose conditions through RAS–PKM2–mediated metabolic reprogramming that reinforces the Warburg phenotypeSemantic proximity Read

Robust identification of shared key genomic biomarkers for diagnosis and therapies of pancreatic cancer with type-2 diabetesSemantic proximity Read

Glycolysis-Based Genes Associated with the Clinical Outcome of Pancreatic Ductal Adenocarcinoma Identified by The Cancer Genome Atlas Data AnalysisSemantic proximity Read

CKS2 Predicts A Poor Prognosis and Contributes to Malignant Progression of Pancreatic CancerSemantic proximity Read